source
- Astellas marks a decade of CLDN18.2 research, eyeing patient selection and treatment sequencingAstellas highlighted a ten‑year journey that took the CLDN18.2 protein from a scientific hypothesis to a validated target in cancer research. The protein, initially noted for its presence on tumor…
- States could counter potential Trump administration vaccine shortages by producing vaccines themselvesJoel Dodge, director of industrial policy at Vanderbilt Policy Accelerator, warns that the Trump administration is considering changes to the Vaccine Injury Compensation Program, a policy that has…